{
    "2020-09-01": [
        [
            {
                "time": "",
                "original_text": "人福医药关于控股股东股份质押的公告",
                "features": {
                    "keywords": [
                        "人福医药",
                        "控股股东",
                        "股份质押"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "人福医药(600079.SH)：已累计回购约2亿元的股份后续根据市况继续实施回购计划",
                "features": {
                    "keywords": [
                        "人福医药",
                        "回购",
                        "股份"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "人福医药(600079.SH)控股股东质押150万股",
                "features": {
                    "keywords": [
                        "人福医药",
                        "控股股东",
                        "股份质押"
                    ],
                    "sentiment_score": -0.5,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "上市公司创新药8月报告：第一梯队在研品种近百个，抗肿瘤药占半壁江山",
                "features": {
                    "keywords": [
                        "创新药",
                        "在研品种",
                        "抗肿瘤药"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药",
                        "生物科技"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}